These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11939684)

  • 41. Lepirudin in the management of patients with heparin-induced thrombocytopenia.
    Petros S
    Biologics; 2008 Sep; 2(3):481-90. PubMed ID: 19707378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J; Jörg I; Fenyvesi T; Piazolo L
    J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation.
    Homoncik M; Pernerstorfer T; Reiter R; Knechtelsdorfer M; Quehenberger P; Jilma B
    Thromb Res; 2002 Oct; 108(1):91-5. PubMed ID: 12586138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.
    Manfredi JA; Wall RP; Sane DC; Braden GA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study.
    Koster A; Chew D; Gründel M; Hausmann H; Grauhan O; Kuppe H; Spiess BD
    Anesth Analg; 2003 May; 96(5):1316-1319. PubMed ID: 12707125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulant.
    Salmela B; Joutsi-Korhonen L; Saarela E; Lassila R
    Thromb Res; 2010 Jun; 125(6):538-44. PubMed ID: 20181379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring of hirudin therapy with the Thrombelastograph.
    Pivalizza EG
    J Clin Anesth; 2002 Sep; 14(6):456-8. PubMed ID: 12393117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.
    Cochran K; DeMartini TJ; Lewis BE; O Brien J; Steen LH; Grassman ED; Leya F
    J Invasive Cardiol; 2003 Nov; 15(11):617-21. PubMed ID: 14608129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
    Yusuf S
    Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Image of the month. Heparin-induced thrombocytopenia: stop all heparin therapy and treat with lepirudin.
    Bush RL; Lin PH; Lumsden AB
    Arch Surg; 2002 Feb; 137(2):221-2. PubMed ID: 11822964
    [No Abstract]   [Full Text] [Related]  

  • 53. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of continuous venovenous hemofiltration for reversal of anticoagulation with lepirudin post-cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia after heart transplantation.
    Saravanan P; Rege K; Falter F
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):269-72. PubMed ID: 17418747
    [No Abstract]   [Full Text] [Related]  

  • 55. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
    Kautzleben M; Stein G; Sperschneider H; Nowak G
    Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular drug highlight: hirudin.
    Cheng-Lai A
    Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
    Tardy-Poncet B; Charier D; Diconne E; Zeni F; Garraud O; Tardy B; Campos L
    Br J Haematol; 2009 Aug; 146(4):456-7. PubMed ID: 19519692
    [No Abstract]   [Full Text] [Related]  

  • 60. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.